| Literature DB >> 35383074 |
Mareike Willmes1, Timur Sellmann2,3, Norbert Semmer4, Franziska Tschan5, Dietmar Wetzchewald1, Heidrun Schwager1, S G Russo3,6,7, Stephan Marsch8.
Abstract
OBJECTIVES: Guidelines recommend family presence to be offered during cardiopulmonary resuscitation (CPR). Data on the effects of family presence on the quality of CPR and rescuers' workload and stress levels are sparse and conflicting. This randomised trial investigated the effects of family presence on quality of CPR, and rescuers' perceived stress.Entities:
Keywords: accident & emergency medicine; adult intensive & critical care; cardiology; health policy; medical ethics
Mesh:
Year: 2022 PMID: 35383074 PMCID: PMC8983997 DOI: 10.1136/bmjopen-2021-056798
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Consolidated Standards of Reporting Trials flow chart.
Figure 2Hands-on time. Box and whisker plot of the percentage hands-on time. Boxes represent medians and IQR; whiskers delineate the 10th and 90th percentile, respectively.
Figure 3NASA task load index. Box and whisker plot of the ratings of the NASA task load index. Boxes represent medians and interquartile range; whiskers delineate the 10th and 90th percentile respectively. White bars = control group; grey bars = family presence group. MenD = mental demand; PhyD = physical demand; TemD = temporal demand; Frustr = frustration; Perfor = own performance.* = P<0.05 for difference between teams with and without family presence.
Secondary outcomes
| Control group (n=158) | Family presence group (n=160) | Effect of family presence, p value | Effect of leadership, p value | |
| Chest compression | ||||
| Time interval to start of CPR (s) | 14 (10–16) | 15 (11–20) | 0.001 | 0.56 |
| Start of CPR with massage (teams) | 149/158 | 146/160 | 0.39 | 0.71 |
| Start of CPR with defibrillation (teams) | 8/158 | 13/160 | 0.37 | 0.84 |
| Any pause in CPR >10 s (teams) | 29/158 | 30/160 | 0.93 | 0.20 |
| Any pause in CPR >10 s (episodes) | 33 | 32 | 0.79 | 0.57 |
| For rhythm analysis/defibrillation | 11/33 | 14/32 | 0.27 | 0.59 |
| For airway management | 22/33 | 18/32 | 0.51 | 0.53 |
| Chest compression rates (strokes/min) | 120 (115–125) | 119 (111–127) | 0.23 | 0.54 |
| Compression rates <100/min (teams) | 6/158 | 11/160 | 0.32 | 0.95 |
| Within-team variance in four cycles (%) | 10 (7–14) | 11 (7–15) | 0.19 | 0.07 |
| Change overs (n) | 2 (2–3) | 2 (2–3) | 0.89 | 0.65 |
| Defibrillation | ||||
| Time of first defibrillation (s) | 62 (47–102) | 72 (52–99) | 0.49 | 0.15 |
| VF not recognised ≥once (teams) | 10/158 | 3/160 | 0.14 | 0.08 |
| Single shock defibrillation only (teams) | 157/158 | 159/160 | 0.99 | 0.99 |
| Shock with adequate energy (teams) | 158/158 | 158/160 | 0.99 | 0.99 |
| Restart CPR ≥4 s ≥once (teams) | 50/158 | 53/160 | 0.78 | 0.45 |
| Restart CPR ≥4 s (episodes) | 64 | 68 | 0.79 | 0.24 |
| Airway management | ||||
| Advanced airway management (teams) | 153/158 | 156/160 | 0.47 | 0.59 |
| Endotracheal tube: supraglottic airway | 52:101 | 67:89 | 0.21 | 0.83 |
| Timing of AAM (in cycle 1:2:3:4) | 40:97:14:2 | 41:95:18:2 | 0.90 | 0.18 |
| Ventilation rate before AAM (b/min) | 6 (4–10) | 4 (4–8) | 0.09 | 0.42 |
| Ventilation rate after AAM (b/min) | 17 (11–24) | 17 (11–25) | 0.97 | 0.59 |
| Medication | ||||
| Epinephrine administered (teams) | 108/158 | 114/160 | 0.56 | 0.42 |
| Correct dose administered (teams) | 108/108 | 114/114 | 0.99 | 0.99 |
| Second dose after 3–5 min (teams) | 3/15 | 4/15 | 0.67 | 0.97 |
| Amiodarone administered (teams) | 132/158 | 133/160 | 0.64 | 0.32 |
| Correct dose administered (teams) | 132/132 | 133/133 | 0.99 | 0.99 |
| Administered after epinephrine AND third shock (teams) | 50/132 | 50/133 | 0.90 | 0.89 |
| Administered before epinephrine (teams) | 80/132 | 82/133 | 0.91 | 0.43 |
| Incorrect ACLS drug administered (teams) | 0/158 | 0/160 | 0.99 | 0.99 |
Data are medians (IQR). AAM, advanced airway management.
ACLS, Advanced Cardiovascular Life Support; CPR, cardiopulmonary resuscitation; VF, Ventricular fibrillation.